ES2171283T3 - Sistema de administracion de farmacos para dos o mas substancias activas. - Google Patents
Sistema de administracion de farmacos para dos o mas substancias activas.Info
- Publication number
- ES2171283T3 ES2171283T3 ES98201128T ES98201128T ES2171283T3 ES 2171283 T3 ES2171283 T3 ES 2171283T3 ES 98201128 T ES98201128 T ES 98201128T ES 98201128 T ES98201128 T ES 98201128T ES 2171283 T3 ES2171283 T3 ES 2171283T3
- Authority
- ES
- Spain
- Prior art keywords
- administration system
- drug administration
- progestogenic
- active substances
- compositional
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Reproductive Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A UN SISTEMA DE ADMINISTRACION DE FARMACOS, PREFERENTEMENTE EN UNA FORMA EN ANILLO ADECUADA PARA LA ADMINISTRACION VAGINAL, PARA LA LIBERACION SIMULTANEA DE UN COMPUESTO ESTEROIDEO PROGESTOGENICO Y UN COMPUESTO ESTEROIDEO ESTROGENICO EN UNA RELACION FISIOLOGICA FIJA DURANTE UN PERIODO DE TIEMPO PROLONGADO. EL SISTEMA DE ADMINISTRACION DE FARMACOS COMPRENDE AL MENOS UN COMPARTIMIENTO QUE COMPRENDE UN NUCLEO DE POLIMERO TERMOPLASTICO QUE CONTIENE LA MEZCLA DE LOS COMPUESTOS PROGESTOGENICOS Y ESTROGENICOS Y UNA PELICULA DE POLIMERO TERMOPLASTICO, ESTANDO EL COMPUESTO PROGESTOGENICO INICIALMENTE DISUELTO EN EL MATERIAL DEL NUCLEO DE POLIMERO EN UN GRADO RELATIVAMENTE BAJO DE SUPERSATURACION.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97201098 | 1997-04-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2171283T3 true ES2171283T3 (es) | 2002-09-01 |
Family
ID=8228203
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES98201128T Expired - Lifetime ES2171283T3 (es) | 1997-04-11 | 1998-04-09 | Sistema de administracion de farmacos para dos o mas substancias activas. |
Country Status (27)
Country | Link |
---|---|
US (1) | US5989581A (es) |
EP (1) | EP0876815B1 (es) |
JP (2) | JP4982670B2 (es) |
KR (1) | KR100492676B1 (es) |
CN (1) | CN1163222C (es) |
AR (1) | AR011709A1 (es) |
AT (1) | ATE211646T1 (es) |
AU (1) | AU726934B2 (es) |
BR (1) | BR9801027B1 (es) |
CA (1) | CA2233753C (es) |
CZ (1) | CZ294099B6 (es) |
DE (1) | DE69803112T2 (es) |
DK (1) | DK0876815T3 (es) |
ES (1) | ES2171283T3 (es) |
HK (1) | HK1016886A1 (es) |
HU (1) | HU222343B1 (es) |
ID (1) | ID21259A (es) |
IL (2) | IL123813A0 (es) |
NO (1) | NO320394B1 (es) |
NZ (1) | NZ330145A (es) |
PL (1) | PL192449B1 (es) |
PT (1) | PT876815E (es) |
RU (1) | RU2206325C2 (es) |
SG (1) | SG65061A1 (es) |
TR (1) | TR199800648A1 (es) |
TW (1) | TW358031B (es) |
ZA (1) | ZA982911B (es) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8753667B2 (en) | 2009-07-21 | 2014-06-17 | The Population Council, Inc. | Multi-layered gradient vaginal ring |
Families Citing this family (86)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL123813A0 (en) * | 1997-04-11 | 1998-10-30 | Akzo Nobel Nv | Drug delivery system for two or more active substances |
US6039968A (en) † | 1997-06-24 | 2000-03-21 | Hoechst Marion Roussel | Intravaginal drug delivery device |
US6361780B1 (en) * | 1998-11-12 | 2002-03-26 | Cardiac Pacemakers, Inc. | Microporous drug delivery system |
US6217895B1 (en) * | 1999-03-22 | 2001-04-17 | Control Delivery Systems | Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
US6371970B1 (en) | 1999-07-30 | 2002-04-16 | Incept Llc | Vascular filter having articulation region and methods of use in the ascending aorta |
US7369463B1 (en) | 2000-02-21 | 2008-05-06 | N.V. Organon | Electronic alarm timer for use with a medical regimen |
US6375972B1 (en) | 2000-04-26 | 2002-04-23 | Control Delivery Systems, Inc. | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
US20040115268A1 (en) * | 2000-04-26 | 2004-06-17 | Control Delivery Systems, Inc. | Systemic delivery of antiviral agents |
US7187980B2 (en) * | 2001-11-09 | 2007-03-06 | Oscor Inc. | Cardiac lead with steroid eluting ring |
TWI297685B (en) | 2002-04-04 | 2008-06-11 | Organon Nv | Non-steroidal progesterone receptor modulators |
BR0309844A (pt) * | 2002-05-07 | 2005-02-15 | Control Delivery Sys Inc | Processos para formação de um dispositivo para a distribuição de droga |
US8871241B2 (en) * | 2002-05-07 | 2014-10-28 | Psivida Us, Inc. | Injectable sustained release delivery devices |
KR20050072812A (ko) | 2002-11-07 | 2005-07-12 | 악조 노벨 엔.브이. | 안드로겐-수용체와 관련된 질병의 치료에 효과적인 인돌 |
EP1576189B1 (en) * | 2002-12-16 | 2007-09-12 | N.V. Organon | Vessel, method and apparatus for dissolution testing of an annular pharmaceutical delivery device |
US7357046B2 (en) * | 2002-12-16 | 2008-04-15 | N. V. Organon | Method for dissolution testing of a pharmaceutical delivery device |
JP4898431B2 (ja) * | 2003-04-29 | 2012-03-14 | ザ ジェネラル ホスピタル コーポレイション | 複数薬物の持続放出のための方法およびデバイス |
TWI336627B (en) * | 2003-05-23 | 2011-02-01 | Organon Nv | Drug delivery system,and use and manufacturing method thereof |
EP1709061A1 (en) * | 2004-01-15 | 2006-10-11 | Warner Chilcott Company Inc. | Di-steroidal prodrugs of ethinyl estradiol |
MXPA06007852A (es) * | 2004-01-15 | 2007-01-31 | Warner Chilcott Co Inc | Profarmacos di-esteroidales de estradiol. |
ES2327247T3 (es) | 2004-03-24 | 2009-10-27 | N.V. Organon | Sistema de administracion de farmacos basado en copolimeros de polietileno y acetato de vinilo. |
TW200531977A (en) | 2004-03-25 | 2005-10-01 | Akzo Nobel Nv | Progesterone receptor modulators |
TW200602317A (en) | 2004-04-23 | 2006-01-16 | Akzo Nobel Nv | Novel androgens |
JP2008520783A (ja) * | 2004-11-16 | 2008-06-19 | ユニベルシテ・ド・リエージュ | ヒドロゲルマトリックスおよびマイクロキャリアを含む活性物質供給システム |
CN100366242C (zh) * | 2005-01-13 | 2008-02-06 | 杭州容立医药科技有限公司 | 防滑脱阴道药物释放体系及其制造工艺和在制药中的应用 |
EP1898834A4 (en) * | 2005-06-20 | 2010-12-15 | Abbeymoor Medical Inc | SELF-ADJUSTABLE ENDO-URETRAL DEVICE AND METHODS OF USE |
TW200727920A (en) * | 2005-06-21 | 2007-08-01 | Organon Nv | New regimens for oral monophasic contraceptives |
US20070015741A1 (en) * | 2005-07-12 | 2007-01-18 | James Keown | Novel prodrugs of estradiol |
EP2390260B1 (en) | 2005-07-12 | 2014-09-17 | Warner Chilcott Company, LLC | Ester derivative of ethinyl estradiol |
CN1899643B (zh) * | 2005-07-20 | 2010-12-29 | 上海市计划生育科学研究所 | 含有抗雌激素和抗孕激素复合制剂的阴道环或宫内释药装置及其制药用途 |
JP5265359B2 (ja) | 2005-08-11 | 2013-08-14 | マサチューセッツ インスティテュート オブ テクノロジー | 膀胱内薬物送達デバイスおよび方法 |
US20070077269A1 (en) * | 2005-10-04 | 2007-04-05 | Woodward John R | Method of birth control and hormone regulation |
US7989442B2 (en) | 2006-09-27 | 2011-08-02 | N.V. Organon | Progesterone receptor modulators |
JP2010510290A (ja) * | 2006-11-22 | 2010-04-02 | ナームローゼ・フエンノートチヤツプ・オルガノン | ミルタザピンのための膣送達系 |
TW200840595A (en) * | 2006-12-12 | 2008-10-16 | Organon Nv | Oral contraceptive spray |
US8063037B2 (en) | 2007-05-07 | 2011-11-22 | N. V. Organon | Progesterone receptor modulators |
TW200930343A (en) * | 2007-09-21 | 2009-07-16 | Organon Nv | Drug delivery system |
EP2231254B9 (en) * | 2007-12-11 | 2015-04-08 | Massachusetts Institute of Technology | Implantable drug delivery device |
KR101794899B1 (ko) * | 2008-08-09 | 2017-11-07 | 메사츄세츠 인스티튜트 어브 테크놀로지 | 남성 비뇨생식기 및 주위 조직을 치료하는 방법 및 체내이식형 약물 전달 장치 |
US20100040671A1 (en) * | 2008-08-12 | 2010-02-18 | Ahmed Salah U | Intravaginal Devices With a Rigid Support, Methods of Making, and Uses Thereof |
US20110280922A1 (en) * | 2008-11-07 | 2011-11-17 | Combinent Biomedical Systems, Inc. | Devices and methods for treating and/or preventing diseases |
FI121000B (fi) * | 2008-11-19 | 2010-06-15 | Bayer Schering Pharma Oy | Intravaginaalinen antojärjestelmä ja menetelmä sen valmistamiseksi |
UY32492A (es) | 2009-03-17 | 2010-10-29 | Organon Nv | Dispositivo de suministro de droga zootécnica. |
CN102481450B (zh) | 2009-04-07 | 2015-09-16 | 威斯特天主教保健中心 | 子宫电刺激系统及方法 |
US8568374B2 (en) * | 2009-05-04 | 2013-10-29 | Merck Sharp & Dohme B.V. | Intrauterine system |
CN102596097B (zh) | 2009-06-03 | 2015-05-20 | 弗赛特实验室有限责任公司 | 一种眼插入件 |
CN102470237A (zh) | 2009-06-26 | 2012-05-23 | 塔里斯生物医药公司 | 用于可植入药物递送装置的固体药物片剂 |
US9017312B2 (en) | 2009-09-10 | 2015-04-28 | Taris Biomedical Llc | Implantable device for controlled drug delivery |
AU2011238710B2 (en) * | 2010-03-28 | 2015-08-20 | Evestra, Inc. | Intravaginal drug delivery device |
WO2011156674A2 (en) | 2010-06-10 | 2011-12-15 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Thioether prodrug compositions as anti-hiv and anti-retroviral agents |
US8580294B2 (en) | 2010-10-19 | 2013-11-12 | International Partnership For Microbicides | Platinum-catalyzed intravaginal rings |
WO2012058289A2 (en) | 2010-10-27 | 2012-05-03 | Dignity Health | Uterine electrical stimulation system and method |
US9872983B2 (en) | 2010-10-27 | 2018-01-23 | Dignity Health | Uterine electrical stimulation system and method |
SG191893A1 (en) | 2011-01-10 | 2013-08-30 | Taris Biomedical Inc | Lidocaine regimen for the use of sustained treatment of bladder pain and irritative voiding |
KR101263916B1 (ko) | 2011-01-11 | 2013-05-13 | 이장희 | 성 호르몬 방출 장치 및 이를 이용한 동물 피임 및 발정 유도 방법 |
ES2637388T3 (es) * | 2011-02-04 | 2017-10-13 | Taris Biomedical, Inc. | Dispositivo implantable para la liberación controlada de un fármaco de baja solubilidad |
EP2734262B1 (en) * | 2011-07-20 | 2018-02-28 | Patrick F. Kiser | Intravaginal rings for drug delivery |
WO2013029194A1 (es) | 2011-08-26 | 2013-03-07 | Universidad De Santiago De Chile | Uso de los anti-inflamatorios no esteroidales meloxicam y piroxicam, por via intravaginal, para la interrupción del proceso ovulatorio en la mujer |
CA2884030C (en) | 2012-09-03 | 2018-04-10 | Ecosea Farming S.A. | Reservoir-cage submersion system for the culture and/or containment of hydrobiological species |
EA201590903A1 (ru) | 2012-11-22 | 2015-11-30 | Байер Фарма Акциенгезельшафт | Применение и режим приема фармацевтической композиции, содержащей левоноргестрел и ингибитор цог, для контрацепции по мере необходимости ("on-demand") |
DK2964088T3 (da) | 2013-03-08 | 2023-06-06 | Li Galli B V I O | Vaginalt lægemiddeladministrations- og/eller diagnosesystem |
SG10201708522SA (en) | 2013-03-15 | 2017-12-28 | Taris Biomedical Llc | Drug delivery devices with drug-permeable component and methods |
CA2919215C (en) | 2013-08-19 | 2022-11-29 | Taris Biomedical Llc | Multi-unit drug delivery devices and methods |
WO2015035003A1 (en) | 2013-09-05 | 2015-03-12 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Thioether prodrug compositions as anti-hiv and anti-retroviral agents |
WO2015055789A1 (en) | 2013-10-17 | 2015-04-23 | Bayer Pharma Aktiengesellschaft | INTRAVAGINAL USE OF 18-METHYL-15ß,16ß-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONES, INTRAVAGINAL RINGS COMPRISING 18-METHYL-15ß,16ß-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONES, AND USE THEREOF IN CONTRACEPTION |
US10137031B2 (en) | 2013-11-14 | 2018-11-27 | International Partnership For Microbicides, Inc. | Combination therapy intravaginal rings |
US10413504B2 (en) | 2013-12-11 | 2019-09-17 | Merck Sharp & Dohme Corp. | Intravaginal ring drug delivery system |
US10596103B2 (en) | 2013-12-11 | 2020-03-24 | Merek Sharp & Dohme B.V. | Drug delivery system for delivery of anti-virals |
EP3277241B1 (en) | 2015-03-31 | 2023-12-20 | Merck Sharp & Dohme B.V. | Vaginal ring applicator |
US20160296532A1 (en) | 2015-04-13 | 2016-10-13 | Forsight Vision5, Inc. | Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent |
JP7425534B2 (ja) | 2015-04-23 | 2024-01-31 | タリス バイオメディカル エルエルシー | 薬物透過性構成要素を有する薬物送達デバイス及び方法 |
CA2985717A1 (en) | 2015-05-13 | 2016-11-17 | Bayer Oy | A long acting drug delivery device and its use in contraception |
EP3272333A1 (en) | 2016-07-22 | 2018-01-24 | Chemo Research, S.L. | Vaginal composition comprising a combination of estrogen and vitamin d |
EP3395335A1 (en) | 2017-04-24 | 2018-10-31 | Kern Pharma, S.L. | Vaginal ring for the simultaneous release of two active ingredients |
DE102017113166A1 (de) * | 2017-06-14 | 2018-12-20 | Amw Gmbh | Depotform zur Abgabe eines Östrogen-Wirkstoffs |
US11103460B2 (en) | 2017-08-07 | 2021-08-31 | Board Of Regents, The University Of Texas System | Fabrication methods for nanodelivery systems for long term controlled delivery of active pharmaceutical ingredients |
CN111989068A (zh) | 2018-05-24 | 2020-11-24 | 塞拉尼斯伊娃高性能聚合物公司 | 用于持续释放大分子药物化合物的可植入器件 |
WO2019226516A1 (en) | 2018-05-24 | 2019-11-28 | Celanese EVA Performance Polymers Corporation | Implantable device for sustained release of a macromolecular drug compound |
CN113365634A (zh) * | 2018-12-11 | 2021-09-07 | 卢品公司 | 超低剂量雌激素组合的药物递送系统及其方法和用途 |
US10632066B1 (en) | 2019-02-01 | 2020-04-28 | The Population Council, Inc. | Method of providing birth control |
US11529308B2 (en) | 2019-06-21 | 2022-12-20 | The Population Council, Inc. | System for providing birth control |
US10918649B2 (en) | 2019-06-21 | 2021-02-16 | The Population Council, Inc. | System for providing birth control |
US11439588B2 (en) | 2019-10-12 | 2022-09-13 | National Research Institute For Family Planning | Vaginal sustained-release drug delivery system for luteal support, method for preparation and use thereof |
CA3158651A1 (en) | 2019-11-27 | 2021-06-03 | Marc M. Baum | Permeable skin sustained release drug delivery device |
USD935018S1 (en) | 2020-04-07 | 2021-11-02 | The Population Council, Inc. | Contraceptive |
WO2023133517A1 (en) | 2022-01-06 | 2023-07-13 | Oak Crest Institute Of Science | Subdermal implant for sustained drug delivery |
WO2024115763A1 (en) | 2022-12-02 | 2024-06-06 | Vari Bioscience Gmbh | Estriol vaginal ring |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3040978A1 (de) * | 1980-10-28 | 1982-05-27 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Vaginalring |
ZA857643B (en) * | 1984-10-12 | 1986-05-28 | Akzo Nv | Release system for two or more active substances |
US4816258A (en) * | 1987-02-26 | 1989-03-28 | Alza Corporation | Transdermal contraceptive formulations |
ATE86484T1 (de) * | 1987-08-08 | 1993-03-15 | Akzo Nv | Kontrazeptives implantat. |
JPH03123727A (ja) * | 1989-10-04 | 1991-05-27 | Nitto Denko Corp | 経皮吸収製剤 |
DE69616551T2 (de) * | 1995-07-04 | 2002-05-29 | Akzo Nobel Nv | Ringförmige vorrichtung |
US5906830A (en) * | 1995-09-08 | 1999-05-25 | Cygnus, Inc. | Supersaturated transdermal drug delivery systems, and methods for manufacturing the same |
IL123813A0 (en) * | 1997-04-11 | 1998-10-30 | Akzo Nobel Nv | Drug delivery system for two or more active substances |
-
1998
- 1998-03-24 IL IL12381398A patent/IL123813A0/xx unknown
- 1998-03-24 TW TW087104397A patent/TW358031B/zh not_active IP Right Cessation
- 1998-03-31 CA CA002233753A patent/CA2233753C/en not_active Expired - Lifetime
- 1998-04-01 SG SG1998000681A patent/SG65061A1/en unknown
- 1998-04-02 ID IDP980503A patent/ID21259A/id unknown
- 1998-04-03 TR TR1998/00648A patent/TR199800648A1/xx unknown
- 1998-04-06 ZA ZA982911A patent/ZA982911B/xx unknown
- 1998-04-07 AR ARP980101575A patent/AR011709A1/es active IP Right Grant
- 1998-04-07 NZ NZ330145A patent/NZ330145A/xx not_active IP Right Cessation
- 1998-04-08 AU AU60751/98A patent/AU726934B2/en not_active Expired
- 1998-04-08 US US09/056,700 patent/US5989581A/en not_active Expired - Lifetime
- 1998-04-08 NO NO19981638A patent/NO320394B1/no not_active IP Right Cessation
- 1998-04-09 ES ES98201128T patent/ES2171283T3/es not_active Expired - Lifetime
- 1998-04-09 AT AT98201128T patent/ATE211646T1/de active
- 1998-04-09 RU RU98106470/14A patent/RU2206325C2/ru active
- 1998-04-09 PT PT98201128T patent/PT876815E/pt unknown
- 1998-04-09 DE DE69803112T patent/DE69803112T2/de not_active Expired - Lifetime
- 1998-04-09 EP EP98201128A patent/EP0876815B1/en not_active Expired - Lifetime
- 1998-04-09 DK DK98201128T patent/DK0876815T3/da active
- 1998-04-09 BR BRPI9801027-1A patent/BR9801027B1/pt not_active IP Right Cessation
- 1998-04-10 HU HU9800863A patent/HU222343B1/hu active IP Right Grant
- 1998-04-10 KR KR10-1998-0012762A patent/KR100492676B1/ko not_active IP Right Cessation
- 1998-04-10 JP JP09887698A patent/JP4982670B2/ja not_active Expired - Lifetime
- 1998-04-10 CZ CZ19981102A patent/CZ294099B6/cs unknown
- 1998-04-10 PL PL325774A patent/PL192449B1/pl unknown
- 1998-04-10 CN CNB981080871A patent/CN1163222C/zh not_active Expired - Lifetime
-
1999
- 1999-03-24 IL IL12381399A patent/IL123813A/en not_active IP Right Cessation
- 1999-05-04 HK HK99101986A patent/HK1016886A1/xx not_active IP Right Cessation
-
2009
- 2009-08-06 JP JP2009183379A patent/JP2009256378A/ja active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8753667B2 (en) | 2009-07-21 | 2014-06-17 | The Population Council, Inc. | Multi-layered gradient vaginal ring |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2171283T3 (es) | Sistema de administracion de farmacos para dos o mas substancias activas. | |
ATE136792T1 (de) | Zellmembran-mischungsmittel enthaltende molekularkonjugate | |
ES2126536B1 (es) | "preparado farmaceutico para administracion intranasal y procedimientopara su produccion". | |
PT850046E (pt) | Microemulsoes para utilizacao como veiculos para administracao de compostos activos | |
ES2181055T3 (es) | Formulaciones galenicas que contienen antagonistas de opiaceos. | |
TR200000517T2 (tr) | Piperidinoalkanol-Konjesyon azaltıcıdan oluşan kombinasyona yönelik farmasötik kompozisyon. | |
DE69721481D1 (de) | Wirkstoffformulierungen mit verzögerter freisetzung | |
MX9101391A (es) | Composicion farmaceutica en forma de gel,contenida dentro de un envase | |
DE69517838T2 (de) | Intrauterine Empfängnisverhütungsvorrichtung | |
ES2010648T3 (es) | Formulaciones farmaceuticas de sustancias labiles frente a los acidos para uso oral. | |
PE20051038A1 (es) | Uso extendido de combinacion que comprende estrogenos y progestinas | |
AR023806A1 (es) | Uso de una mezcla de peptidos para la manufactura de un agente terapeutico para la profilaxis y/o el tratamiento del cancer, las composicionesfarmaceuticas y vacunas que contienen dicha mezcla y los procedimientos de preparacion de dichas composiciones y vacunas | |
MX9300407A (es) | Derivados azabiciclicos usados en la fabricacion de medicamentos, composiciones que los contienen y procedimiento para su preparacion. | |
BR0116569A (pt) | Cartucho e sistema dispensador | |
RS50246B (sr) | Tableta za sisanje, koja sadrži ambroksol | |
DE59510583D1 (de) | Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid | |
ES2165970T3 (es) | Forma farmaceutica solida con principio activo distribuido en un material polimerico. | |
HN1999000174A (es) | Formulacion medicamentosa acuisa para administracion oral. | |
AR002735A1 (es) | Formulaciones liquidas de sustancias insecticidas activas. | |
ES2090549T3 (es) | Sistema vehiculo de principio activo o de pigmento que permite la administracion por via oral a los peces y crustaceos. | |
PE20020055A1 (es) | Formulaciones estables liquidas y solidas que comprenden una antihistamina no sedante y un descongestionante nasal | |
DE69416034D1 (de) | Pharmazeutische Zubereitung zur rektalen Verabreichung von pharmakologisch wirksamen Verbindungen | |
AR004207A1 (es) | Derivados de acido nodulisporico, una composición farmaceutica que los contiene y el uso de los mismos en la preparación de un medicamento. | |
TH22662A (th) | สารสูตรผสมของ 2-คลอโร-2'-ดีออกซิแอดีโนซินชนิดละลายได้ | |
ECSP003317A (es) | Preparacion de globulos con una concentracion con hasta 90% de una sustancia activa farmaceutica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 876815 Country of ref document: ES |